Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. (Q52629916)

4 May 2018

http://europepmc.org/abstract/MED/29580818

title

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. (English)

1 reference

4 May 2018

http://europepmc.org/abstract/MED/29580818

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Matthew Bates

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Novel N Chegou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Alimuddin Zumla

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1

Gerhard Walzl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Timothy D McHugh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ruth McNerney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

23 March 2018

1 reference

4 May 2018

http://europepmc.org/abstract/MED/29580818

published in

Lancet Infectious Diseases

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

e199-e210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Silent mutation in rpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Concise gene signature for point-of-care classification of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Metabolomics specificity of tuberculosis plasma revealed by (1)H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Identification of serum microRNA biomarkers for tuberculosis using RNA-seq

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Human gene expression profiles of susceptibility and resistance in tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Diagnosis of childhood tuberculosis and host RNA expression in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

The architecture of diagnostic research

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

A metabolic biosignature of early response to anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

Imaging in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930111-7

7 January 2021

10.1016/S1473-3099(18)30111-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29580818%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference